References
- Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126. https://doi.org/10.1093/eurheartj/ehac262
- Talib AK, Nogami A. Catheter ablation for Brugada syndrome. Korean Circ J 2020;50:289-301. https://doi.org/10.4070/kcj.2019.0344
- Campbell T, Bennett RG, Kotake Y, Kumar S. Updates in ventricular tachycardia ablation. Korean Circ J 2021;51:15-42. https://doi.org/10.4070/kcj.2020.0436
- Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217-20. https://doi.org/10.1038/nm.2471
- Wang J, Xu C, Wong YK, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering (Beijing) 2019;5:32-9. https://doi.org/10.1016/j.eng.2018.11.011
- Jang S, Jeong MH, Lim KS, et al. Effect of stents coated with artemisinin or dihydroartemisinin in a porcine coronary restenosis model. Korean Circ J 2017;47:115-22. https://doi.org/10.4070/kcj.2016.0278
- Jeong HK, Hong SN, Yoon N, Lee KH, Park HW, Cho JG. Antiarrhythmic effect of artemisinin in an ex-vivo model of Brugada syndrome induced by NS5806. Korean Circ J 2023;53:239-50. https://doi.org/10.4070/kcj.2022.0312
- Saadeh K, Nantha Kumar N, Fazmin IT, Edling CE, Jeevaratnam K. Anti-malarial drugs: mechanisms underlying their proarrhythmic effects. Br J Pharmacol 2022;179:5237-58. https://doi.org/10.1111/bph.15959
- Kim D, Yang PS, Joung B. Optimal rhythm control strategy in patients with atrial fibrillation. Korean Circ J 2022;52:496-512. https://doi.org/10.4070/kcj.2022.0078